Home > Call For Paper > Vaccine Research and Development

Vaccine Research and Development

Vaccine research and development (R&D) is crucial for creating effective vaccines against diseases, particularly in regions with high economic and health burdens. Initiated by the World Health Organization (WHO), R&D efforts focus on diseases lacking vaccines or with underutilized options, prioritizing low and middle-income countries. Traditionally spanning several years, the process involves basic research, preclinical studies, and rigorous clinical trials to assess safety, immunogenicity, and efficacy in human volunteers. Recent advancements, driven by unprecedented investments and global collaborations, have accelerated vaccine development, notably with COVID-19 vaccines using mRNA and viral vector technologies. Beyond development, R&D aims to optimize vaccine impact, inform introduction decisions, and enhance post-licensure monitoring for sustained effectiveness in immunization programs. This concerted effort underscores the importance of vaccines in global health strategies, addressing infectious diseases and improving public health worldwide.

  • Preclinical Studies
  • Clinical Trials
  • Vaccine Platforms
  • Immunogenicity and Efficacy
  • Safety and Tolerability
  • Regulatory Approval
  • Global Collaboration
  • Post-Marketing Surveillance
SUBMIT ABSTRACT
  +1-404-759-9729
Subscribe To Our Newsletter
425077
TOP